home / stock / agtx / agtx quote
Last: | $0.023 |
---|---|
Change Percent: | 0.0% |
Open: | $0.04045 |
Close: | $0.023 |
High: | $0.04045 |
Low: | $0.023 |
Volume: | 133,400 |
Last Trade Date Time: | 05/06/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.023 | $0.04045 | $0.023 | $0.04045 | $0.023 | 133,400 | 05-06-2024 |
$0.0322 | $0.041 | $0.0322 | $0.041 | $0.0322 | 1,256 | 03-21-2024 |
$0.0321 | $0.0321 | $0.0321 | $0.0321 | $0.0321 | 300 | 03-06-2024 |
$0.05 | $0.05 | $0.05 | $0.05 | $0.05 | 100 | 02-29-2024 |
$0.05 | $0.049 | $0.05 | $0.05 | $0.049 | 79,980 | 01-29-2024 |
$0.031 | $0 | $0.031 | $0 | $0 | 42 | 12-18-2023 |
$0.031 | $0.031 | $0.031 | $0.031 | $0.031 | 115 | 12-14-2023 |
$0.031 | $0 | $0.031 | $0 | $0 | 2 | 12-13-2023 |
$0.031 | $0.031 | $0.031 | $0.031 | $0.031 | 221 | 12-12-2023 |
$0.03217 | $0.03217 | $0.03217 | $0.03217 | $0.03217 | 100 | 12-11-2023 |
$0.032 | $0 | $0.032 | $0 | $0 | 1 | 11-27-2023 |
$0.032 | $0.032 | $0.032 | $0.032 | $0.032 | 300 | 11-17-2023 |
$0.0301 | $0.0301 | $0.0301 | $0.0301 | $0.0301 | 8,000 | 10-23-2023 |
$0.0475 | $0.0475 | $0.0475 | $0.0475 | $0.0475 | 2,491 | 10-18-2023 |
$0.071 | $0.0715 | $0.071 | $0.0715 | $0.071 | 9,203 | 10-13-2023 |
$0.0715 | $0.0715 | $0.0715 | $0.0715 | $0.0715 | 370 | 09-26-2023 |
$0.0715 | $0.0715 | $0.0715 | $0.0715 | $0.0715 | 100 | 09-20-2023 |
$0.1188 | $0.1188 | $0.1188 | $0.1188 | $0.1188 | 100 | 09-18-2023 |
$0.08485 | $0.129 | $0.08485 | $0.129 | $0.062 | 1,156 | 08-16-2023 |
$0.06 | $0.06 | $0.06 | $0.06 | $0.06 | 100 | 08-01-2023 |
News, Short Squeeze, Breakout and More Instantly...
Agentix Corp - Ordinary Shares Company Name:
AGTX Stock Symbol:
OTCMKTS Market:
Phoenix, Arizona--(Newsfile Corp. - January 4, 2022) - The Stock Day Podcast welcomed AGENTIX (OTC Pink: AGTX) ("the Company"), a clinical-stage biopharmaceutical company focused on the development of innovative therapeutics for the treatment of metabolic diseases including type 2 diabetes mel...
New York, New York--(Newsfile Corp. - December 21, 2021) - AGENTIX Corporation (OTC Pink: AGTX), a clinical-stage biopharmaceutical company focused on the development of innovative therapeutics for the treatment of metabolic diseases, announced today it has entered into an amendment to a Paten...
New York, New York--(Newsfile Corp. - September 8, 2021) - AGENTIX Corp. (OTC Pink: AGTX), a pharmaceutical company focused on developing innovative therapeutic treatments targeting the endocannabinoid system (ECS) for the treatment of metabolic diseases, announced today it had entered into a ...